Monday, 18 June 2018

Israel's DreaMed gets FDA ok for diabetes management software

TEL AVIV (Reuters) - Israel's DreaMed Diabetes said on Monday the U.S. Food and Drug Administration has approved for marketing its Advisor Pro software to help manage diabetes treatment.


No comments:

Post a Comment